The Center for Scientific Review has selected Dr. Brant Inman, Associate Professor, Division of Urology, to participate in the Cancer Immunopathology and Immunotherapy study section scheduled this June in Bethesda, Maryland. This section reviews NIH applications addressing immunologic therapies for cancer, modulation of immune responses to cancer cells, and antibody-based therapies. The NIH selects participants for study sections through an application process.
Congratulations to Dr. Inman on this achievement!